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This study investigates empirically how past screening behaviour, individual and household characteristics
affect the current uptake of cervical cancer screening in UK. For the conceptual framework, we use a
modified Grossman model which is extended for non-economic factors. A dynamic version of a random
effects panel probit model with initial conditions is estimated on the balanced sub-sample of the data. The
analysis sample is restricted to women of age 16 and older and grouped into different age categories with
respect to the NHS Cervical Screening Programme (NHSCSP). As dataset a balanced panel data of 857
women with 11,998 observations from the British Household Panel Study (BHPS) for the period from 1992
to 2008 is used for the analysis. Results suggest show that previous screening uptake, age, partner status,
employment status and a previous GP visit have a significant influence on the likelihood of the uptake of
cervical cancer screening.
R
eduction of health care costs is one of the priorities for NHS in UK in consideration of tight government
budgets. Prevention is especially important in this context, because health check-ups and screening exams
which are offered by NHS in UK lead to an early detection of diseases. Cervical cancer screening is a typical
example of secondary prevention. Cervical cancer screening has been estimated to cost around £175million a year
in England which includes the cost of treating cervical abnormalities1. Primary Care Trusts (PCTs) are also
responsible for the commissioning of cervical screening from the overall allocation they receive from the
Department of Health.
In contrast to some other types of cancer cervical cancer can normally be effectively treated if it is detected at an
early stage and for women with a diagnosis of cervical cancer curative treatment exist with an excellent survival
prognosis2. Survival figures for England show that around 67 per cent of women diagnosed with cervical cancer
between 2005 and 2009 were alive five years later3. Cervical cancer screening is considered as a good protection
against cervical cancer, because of the early detection of this cancer type and many women who develop cervical
cancer have never been screened4. It is estimated that up to 92% dying from cervical cancer has never been tested.
In 2008, there have been 2250 new registrations of invasive cervical cancer3 and 830 women died from cervical
cancer in England5. It is estimated that cervical cancer screening prevents about 4,500 cases of cervical cancer per
year in the UK6.
Cervical cancer screening started in Britain in the mid-1960s7. By the mid-1980s, although many women were
having regular smear tests, there was concern that those women at greatest risk were not being tested, and that
those who had positive results were not being followed up and treated effectively. Because of these reasons the
NHS Cervical Screening Programme (NHSCSP) was set up in 1988 when the Department of Health instructed all
health authorities to introduce computerised call-recall systems and to meet certain quality standards6. This
programme has invited about 4.5 million women for screening in 2010/11 and 3.4 million women screened in
2010/11 in England8. Most women in the target age group were tested following an invitation and the rest were
screened opportunistically at the suggestion of the sample taker or of thewomanherself1. Invitation by thewoman
is done by the NHS call and recall systemwhich invites womenwho are registered with a GP. It also keeps track of
any follow-up investigation and recalls the woman for screening in three or five years’ time if there is no
abnormality. It is therefore important that all women ensure their GP has their correct name and address details
and inform them if address details change if there has been a change of residence.
Within the NHS Cervical Screening Programme women should receive now their first invitation for routine
screening at 25. In October 2003 there has been a change in national policy for starting age of cervical cancer
screening age which has been raised from age 20 to 25. There was a discussion to lower the starting age again to 20
in England9, however the Advisory committee on cervical screening (ACCS) reviewed the policy of starting
screening at age 25 and agreed not to change the current screening policy in England10. The policy of starting
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screening is different in Scotland andWales, because cervical cancer
screening starts from age 2011,12. The NHS Cervical Screening offers
screening at different intervals depending on age and is free of
charge. The intervals for screening are: age 20 or 25 first invitation,
age 20 or 25–49 3 yearly period since 2003 (changing from a 5 yearly
period before 2003), age 50–64 5 yearly period, age 651 screening
only for those women who have not been screened since age 50 or
who have had recent abnormal tests. Women aged 65 and over are
taken out of the call recall (invitation) system unless they need
ongoing surveillance or follow up. This is considered as necessary
if a womanhas had an abnormal result in any of her threemost recent
tests.Women aged 65 and over who have never had a test are entitled
to one. Although the cervical screening programme is a national
programme, there is considerable variation in the local implementa-
tion of the national guidance and the invitation by the recall system
for cervical screening can differ from the national recommenda-
tion13. This is shown by the fact that 85% of Primary Care Trusts
have invited women for a cervical cancer screening every 3 years and
15% have had amixed policy of inviting every 3 or 5 years depending
on the age of women until 200214.
The success of the NHS Cervical Screening Programme can be
seen by decreasing incidence and mortality rates. First, cervical can-
cer incidence rates have dropped considerably after theNHSCervical
Screening Programme started in the UK in the late 1980s. In UK, the
age-standardised incidence rate almost halved from 16 per 100,000
women in 1986–1988 to 8.5 per 100,000 women in 2006–20081 and
the number of new cases decreased about 35% compared to the
1980s6. Second, the success of cervical cancer screening can be seen
second by the fact that mortality rates in 2008 are nearly 70 per cent
lower (2.4 per 100,000 females) than they were 30 years earlier (7.1
per 100,000 females in 1979)1. A relevant number for judging the
effectiveness of this programme is the coverage rate which measures
the percentage of women in the relevant age group from 25 to 64 who
have been screened in the last five years. There has been an increase
from 61% in 1992/93 to 80% in 200515 and since then there has been a
slight decrease of the coverage rate in the last years: it has been fallen
to 78.6% in 2010/1116,17. Comparing coverage rates between 1995 and
2005 there has been a slight increase for women above 55 and a
decrease for women younger than 34. The purpose of our paper is
to develop a conceptual theoretical framework for analysing cervical
screening uptake and to conduct an empirical analysis controlling for
a large number of individual and household characteristics and to
give policy recommendations.
Results
Economicmodels of preventative health care use. Economic models
for the demand of health care are based on human capital models and
in these models the demand for health goods are derived from the
generic demand for health18. This general framework has also been
adopted for the modelling of the demand for preventative care and
also for the special case of cancer prevention19. Cervical cancer
screening falls within the category of secondary prevention and acts
as self-protection measure which enhances the early detection
probability and reduces the consequences of ill health20. However,
two important aspects which are relevant for the demand of
preventative care are typically not considered at the same time in
detail in models for demand of health care: distinction between
acute and preventative care and uncertainty. Some dynamic econo-
mic models for the demand of health care incorporates uncertainty,
but makes no distinction between acute and preventative care21. Acute
care represents especially the consumption aspect of health whereas
preventative care (i.e. screening services) represents the investment
aspect. Other economic models such as the simplified Grossman
model makes the distinction between acute and preventative care,
but include no uncertainty22. Only one economic model considers
explicitly the demand for preventative health care and uncertainty
in a stochastic dynamic framework23, however does not consider
non-economic factors.
Therefore, our conceptual framework for the uptake of cervical
cancer screening care is based on a human capital approach23, how-
ever it includes further non-economic factors such as non-monetary
barriers. This approach is also supported by previous research which
has investigated determinants of screening uptake in general and
female specific cancer screening such as breast and cervical screening
in particular24. Uptake of screening exams such as pap smears was
not only affected by direct and indirect costs of the screening exams,
but also by a wide range of individual, family characteristics and
other conditions such as attitudes, beliefs, barriers and facilitating
conditions.
Hypotheses. Age can have different effects on the demand for using
health care and also for the demand of prevention. In the Grossmann
model health depreciates with an increasing rate at older ages and so
the health stock falls with increased necessity and demand for
prevention activities. This matches also with the fact, that middle
aged women have a higher risk of developing cervical cancer.Median
age at diagnosis for cervical cancer is in the late 40 s and benefits of
screening with avoiding cervical cancer cases has been shown most
useful for women between their 40 s and late 60 s10. Higher perceived
risk could lead to an increased use of preventive care due to increased
risks of developing cervical cancer in middle age. However, older
individuals have also a shorter pay-off period and returns of
preventions activities would be reduced. The resulting effect of
increasing age is unclear and because of nonlinearities age is
modelled in different age categories starting with age 16–24 as
reference group. Empirical studies find often a negative relation-
ship between age and uptake of cervical and breast cancer
screening25,26. Education increases the uptake of preventative care
for several reasons, because better educated individuals have a
higher efficiency in the production of health. There are possible
further transmission channels for effect of education on uptake
such as increased self-efficacy, confidence, motivation, patience
and social inclusion27. Schooling will be used as a proxy for
education with primary education (ISCED classification) as
reference category and secondary and tertiary education as further
education levels. Females with partners will be more likely to
participate in prevention activities, because partners will take care
for each other and women will show risk-adverse behaviour28,29.
Number and age of children could influence uptake through time
constraints, especially small children may reduce women’s
availability of time for a cervical cancer screening30. For the
children two variables will be used: total number of children living
in the household and number of children under the age of 4.
Household income could have possible different effects on
screening uptake. On one hand it is predicted to have a positive
impact on screening uptake, because higher income leads to an
increase in demand for time in perfect health, however on the
other hand higher income which is induced by a higher salary
increases leisure cost and time cost for prevention activities.
However, there is empirically support that increasing income leads
to higher demand for preventive health care26,31,32. Household
income should have a lower effect on uptake on preventative
services in UK than in other countries, because access to health
care and most of the preventative services is free in UK. Household
income was deflated and transformed in per capita income using the
modified OECD scale to allow for household size and needs33.
Employment status has been shown to be correlated with the
uptake of cervical screening and employed women have a higher
uptake of cervical cancer screening and in some studies it was a
stronger predictor of non-attendance than income and
education28,29. The GP plays a prominent role in the UK health
care system as a gate keeper and this is also the case for the
www.nature.com/scientificreports
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demand of preventative health care, because the GP is the first point
of contact for every non-urgentmedical condition and before visiting
a medical specialist34. In countries with a centralized health system
such with the NHS in the UK the GP is in an important place to
inform the patient about the relevance of prevention and this is also
the case for cervical cancer screening. A higher number of GP visits
should lead to a higher uptake of cervical cancer screening. Self-rated
health status of the individuals can either have a positive or negative
impact on the probability of screening. On one hand, individuals in a
poor health status will try to increase their stock of health and so
demand for preventative health care should increase. On the other
hand it has been found that individuals who are in a poor health
status are less likely to have pap smears andmammograms and this is
especially true for women who reported very low levels of self-rated
health status35 and it is explained that psychological factors such as
anxiety and fear could be important reasons why sicker women avoid
cancer screenings. However a further study has not confirmed this
result, also women with a poor health status have not had a lower
uptake rate of cervical and breast cancer screening25. Variables for
health status are the self-rated health status and the General Health
Questionnaire (GHQ) measure of well-being using the Caseness
scale with a range from 0 (least distressed) to 12 (most distressed).
Reference category for self-rated health status is a self-rated health
status ranging from fair to excellent. Smoking is associated with high
risk health behaviours and a lower probability of using preventative
health care and individuals with risk taking behaviour such as
smokers will have a lower compliance with screening guidelines for
regular test36. For women with non-white ethnicity barriers in form
of cultural understanding and unawareness of cervical cancer risk
can exist and empirical studies have shown its predictive importance
and so these women should have a lower uptake rate37. Ethnicity is
included as a predictor variable for uptake and there are 2 categories:
white (reference category) and non-white. For getting an invitation
or recall for cervical cancer screening women have to be registered
with their local GP or clinic. The information aboutGP registration is
not available, however the BHPS contains information about moved
residence (mover) and for women with moved residence the chance
of missing the invitation letter for the next cervical cancer screening
increases. It is plausible to expect that those who move from location
to location will experience disruptions to their screening access
facilities27. Geographical barriers can exist for preventative care for
individuals living in urban or rural areas38, because access to health
care and time cost as a non-monetary component can play an
important role for the uptake of medical services especially if
services are free39. There are only very few studies which have
investigated the effect of time costs such as travel time on uptake26
and a study which analyse differences for living in a rural or urban
environment has found a lower uptake for women living in rural
areas40. However, on the other hand patients’ links to the doctor
could be tighter in a rural environment as compared to an urban
environment32, so the effect is unclear. There were also regional
dummies for Scotland and Wales included and England was the
reference category. In October 2003 there has been a change in
the national policy for women in the age range between 25 and 49
for the screening interval: before this year there has been a 5-year
screening interval, after this year a 3-year screening interval. One
indicator variable will be used for the relevant age group from 25–49
after the year 2003 to check the effect of this policy change on uptake
and uptake for this age group in this time period should increase.
Analytical results. Figure 1 gives the proportion of women of age 25–
64 who reported to have been taken part in cervical screening in a
certain (wave) of the BHPS in relationship to all women of age (25–
64) in a certain wave of the BHPS. This figure shows a decreasing
participation uptake rate from 33.2% in 1992 to 26.5% in 2008 for
self-reported screening with NHS provision. These average numbers
of uptake per year are consistent with a 3–5 yearly cycle of cervical
screenings which are in line with the medical recommendations for
the age group between 25 and 64 by NHSCSP.
Table 1 presents descriptive statistics for the variables used in our
estimation for the balanced panel and the unbalanced panel to look
for attrition effects. For some variables there exists a difference
between the unbalanced and the balanced panel, so that attrition
effects could have an influence on the estimation41. Because of this
difference and to check the robustness of the results dynamic panel
probit models are estimated for the unbalanced and balanced sample
and a fixed effects linear regression model for the balanced panel.
Table 2 provides the dynamic random effects (RE) probit esti-
mates with initial conditions for the unbalanced panel (UP) (column
1) and for the balanced panel (BP) (column 2) and a fixed effects (FE)
linear regression model for the balanced panel (column 3). The table
is based on a sample of 33,075 observations with 3,758 women for the
unbalanced panel and of 11,998 observations with 857 for the
balanced panel. The unbalanced dynamic random effects probit
model and the linear fixed effects-model model gave similar results
in comparison to the balanced panel model and in the following the
discussion concentrates on the balanced panel, because these estima-
tions are the most reliable ones.
Since we had the repeated screening uptake information for each
of the individuals, it is informative to know how past screening habit
affected the current screening uptake.Womenwho had screened one
year and three years before had a higher probability to participate in
the actual period and the marginal effect showed an increase in
probability of 5,4% if screened one year before and 13,0% if screened
three years before (table 3).
There was a non-linear relationship between age and uptake and
the propensity to be screened fell with rising age and in the age
category 65 it was the lowest one with a decrease of 32,3% to the
reference group. Living with a partner led to a higher probability for
cervical cancer screening with an increase of 3.5%. Women with
small children under age 4 had a lower probability of taking part
in cervical cancer screening and showed a decrease in probability of
2.5% whereas the number of children had no significant influence.
For women who visited their GP last year there was a much higher
probability of cervical cancer screening and the increase in uptake
was 9.1%. The two health status related variables, namely poor self-
rated health status and subjective well-being had no significant
influence. Smoking status as a possible indicator for risky health
behaviour had surprisingly no influence. Also our hypothesis of a
lower probability of screening for non-white women was also not
confirmed. Part- or full time-employment led to an increase to an
increase of 1.6% in uptake. Further socio-economic background vari-
ables such as equivalised household income, education, rural or
urban living and moved residence were not significant. The change
in policy after 2003 for women of age 25–49 with reducing the
recommended time interval from five to three years for this age
group led not to an increase in taking part in cervical cancer screen-
ing. Regional dummy variables for Scotland and Wales were not
significant at the 10%-significance level. Also the Mundlak terms
for the average equivalised household income and the average self-
rated health status showed no significance.
Discussion
Our empirical investigation showed the importance of past screening
behaviour for the recent period and also analysed which socioeco-
nomic characteristics are important for the uptake of cervical cancer
screening in the actual period. For our analysis and estimation we
concentrated on a balanced sample of 857 with 11,998 observations
for the period from 1992 to 2008, because using a balanced panel
offers econometric advantages in comparison to an unbalanced
panel. One important problem of an estimation of an unbalanced
www.nature.com/scientificreports
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Figure 1 | Self-reported cervical cancer screeningwithNHSprovision only. Source: BHPSwaves 1–18. Self-reported cervical cancer screeningwithNHS
provision for women of age 25–64.
Table 1 | Sample characteristics (proportions) for the unbalanced and balanced panel
Variable Unbalanced panel Balanced panel
Cervical screening in t 0.209 0.204
Cervical screening in t-1 0.211 0.213
Cervical screening in t-2 0.219 0.222
Cervical screening in t-3 0.227 0.231
Total HH annual income (mean/sd) 2.990/1.877 3.120/1.853
Living with partner 0.626 0.732
Age between 16 and 24 0.090 0.009
Age between 25 and 49 0.426 0.447
Age between 50 and 64 0.228 0.293
Age 65 and older 0.256 0.251
Moved residence within UK 0.073 0.047
Number of children in household (mean/sd) 0.556/0.946 0.522/0.913
Existence of children in HH aged 0–4 0.089 0.080
Primary education (ISCED) 0.264 0.247
Secondary education (ISCED) 0.429 0.432
Tertiary education (ISCED) 0.307 0.321
Employed part-time or full-time 0.530 0.524
GP visit during last 12 months 0.816 0.810
Subjective Wellbeing (GHQ) (mean/sd) 2.132/3.155 1.972/3.085
Health status: self rated poor 0.109 0.0904
Smoker 0.207 0.166
Region England 0.862 0.869
Region Scotland 0.081 0.079
Region Wales 0.057 0.052
Living in a rural area 0.116 0.138
Ethnic non-white 0.0187 0.0105
Cervical screening policy change 0.0924 0.110
Average health status self rated (mean/sd) 2.260/0.673 2.222/0.656
Average total HH annual income (mean/sd) 2.931/1.449) 3.062/1.408
Source: BHPS waves 1–18.
The unbalanced panel consists of 33,075 observations from 3,758 women and the balanced panel consists of 11,998 observations from 857 women.
www.nature.com/scientificreports
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panel could be attrition bias over time and so we gave estimation of a
balanced panel preference42.
In a context of an individual woman our results can be interpreted
that woman who take part regularly for cervical cancer screening
have a habit of using this preventative health service regularly and
these results can be interpreted in the sense of state dependence43.
There exists a strong positive state dependence for cervical cancer
screening and this result can be explained by adherence to the med-
ical guidelines, i.e. checking in 3-yearly intervals and after inconclus-
ive results. The decreasing uptake with age is in accordance with the
Table 2 | Parameter estimates and standard errors for the uptake of cervical cancer screening
Variable
Model 1 Model 2 Model 3
RE-Probit UP RE-Probit BP FE-Linear BP
Cervical screening in t-1 0.325*** 0.243*** 20.020**
(0.023) (0.038) (0.009)
Cervical screening in t-2 20.202*** 20.278*** 20.151***
(0.023) (0.039) (0.009)
Cervical screening in t-3 0.532*** 0.580*** 0.104***
(0.021) (0.036) (0.009)
Total HH annual income 20.000 0.007 0.002
(0.007) (0.012) (0.003)
Living with partner 0.108*** 0.157*** 0.043**
(0.025) (0.049) (0.019)
Age between 25 and 49 0.154*** 20.229* 20.071*
(0.038) (0.139) (0.040)
Age between 50 and 64 20.123*** 20.478*** 20.116***
(0.042) (0.143) (0.043)
Age 65 and older 21.130*** 21.442*** 20.253***
(0.054) (0.156) (0.046)
Moved residence within UK 0.067** 20.034 20.014
(0.033) (0.068) (0.016)
Number of children in household 0.005 0.037* 0.005
(0.013) (0.023) (0.008)
Existence of children in HH aged 0–4 20.016 20.113** 20.019
(0.032) (0.057) (0.016)
Secondary education (ISCED) 0.026 0.036 0.013
(0.033) (0.058) (0.093)
Tertiary education (ISCED) 0.140*** 0.067 0.023
(0.036) (0.064) (0.104)
Employed part-time or full-time 0.083*** 0.072* 0.022
(0.025) (0.043) (0.013)
GP visit during last 12 months 0.418*** 0.404*** 0.091***
(0.026) (0.044) (0.010)
Subjective Wellbeing (GHQ) 20.001 0.006 0.001
(0.003) (0.005) (0.001)
Health status: self rated poor 0.045 20.013 20.005
(0.036) (0.066) (0.015)
Smoker 0.074*** 0.037 0.033
(0.026) (0.051) (0.022)
Region Scotland 20.049 0.028 20.027
(0.040) (0.073) (0.084)
Region Wales 0.014 20.107 20.063
(0.047) (0.091) (0.085)
Living in a rural area 20.054 20.010 20.028
(0.034) (0.055) (0.030)
Ethnic non-white 20.074 20.187
(0.073) (0.184)
Cervical screening policy change 20.114*** 20.112** 20.046***
(0.029) (0.046) (0.012)
Cervical screening in 1991 0.176*** 0.221***
(0.024) (0.043)
Cervical screening in 1992 0.115*** 0.198***
(0.025) (0.044)
Cervical screening in 1993 0.155*** 0.147***
(0.026) (0.045)
Average health status self rated 20.042** 20.026
(0.020) (0.036)
Average total HH annual income 20.002 0.008
(0.011) (0.020)
*p,0.10, ** p,0.05, *** p,0.010.
The unbalanced panel (UP) consists of 33,075 observations from 3,758 women and the balanced panel (BP) consists of 11,998 observations from 857 women. Reference categories are: living without a
partner, age between 25 and 29, no moved residence within UK , primary education (ISCED), not employed, health status not self-rated poor, no smoker, region England, living in a non-rural area, white
ethnic.
www.nature.com/scientificreports
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shorter pay-off period hypothesis from the human capital theory
approach. The effect of age could be also explained by negative
experience related to the screening procedure itself, or to updated
subjective evaluations on the benefits of screening44. The positive
effect of living with a partner on uptake can be interpreted to be
more risk-averse if living in a partnership. The result that the exist-
ence of children under age 4 leads to a lower uptake of cervical cancer
screening can be explained by the fact that only children of smaller
age are a time constraint, whereas the number of children in the
household or existence of older children leads not to a time con-
straint. Our hypothesis of a lower probability of screening for non-
white women was not confirmed and so no cultural barrier exists for
non-white women over all age group exists. The significance of a GP
visit in the year before the actual wave can be explained by the fact
Table 3 | Marginal effects and standard errors for the uptake of cervical cancer screening
Variable
Model 1 Model 2 Model 3
RE-Probit UP RE-Probit BP FE-Linear BP
Cervical screening in t-1 0.075*** 0.054*** 20.020**
(0.005) (0.009) (0.009)
Cervical screening in t-2 20.046*** 20.062*** 20.151***
(0.005) (0.009) (0.009)
Cervical screening in t-3 0.122*** 0.130*** 0.104***
(0.005) (0.008) (0.009)
Total HH annual income 20.000 0.002 0.002
(0.002) (0.003) (0.003)
Living with partner 0.025*** 0.035*** 0.043**
(0.006) (0.011) (0.019)
Age between 25 and 49 0.035*** 20.051* 20.071*
(0.009) (0.031) (0.040)
Age between 50 and 64 20.028*** 20.107*** 20.116***
(0.010) (0.032) (0.043)
Age between 65 and older 20.259*** 20.323*** 20.253***
(0.012) (0.035) (0.046)
Moved residence within UK 0.015** 20.008 20.014
(0.007) (0.015) (0.016)
Number of children in household 0.001 0.008 0.005
(0.003) (0.005) (0.008)
Existence of children in HH aged 0–4 20.004 20.025** 20.019
(0.007) (0.013) (0.016)
Secondary education (ISCED) 0.006 0.008 0.013
(0.008) (0.013) (0.093)
Tertiary education (ISCED) 0.032*** 0.015 0.023
(0.008) (0.014) (0.104)
Employed part-time or full-time 0.019*** 0.016* 0.022
(0.006) (0.010) (0.013)
GP visit during last 12 months 0.096*** 0.091*** 0.091***
(0.006) (0.010) (0.010)
Subjective Wellbeing (GHQ) 20.000 0.001 0.001
(0.001) (0.001) (0.001)
Health status: self rated poor 0.010 20.003 20.005
(0.008) (0.015) (0.015)
Smoker 0.017*** 0.008 0.033
(0.006) (0.011) (0.022)
Region Scotland 20.011 0.006 20.027
(0.009) (0.016) (0.084)
Region Wales 0.003 20.024 20.063
(0.011) (0.020) (0.085)
Living in a rural area 20.012 20.002 20.028
(0.008) (0.012) (0.030)
Ethnic non-white 20.017 20.042
(0.017) (0.041)
Cervical screening policy change 20.026*** 20.025** 20.046***
(0.007) (0.010) (0.012)
Cervical screening in 1991 0.040*** 0.050***
(0.006) (0.010)
Cervical screening in 1992 0.026*** 0.044***
(0.006) (0.010)
Cervical screening in 1993 0.036*** 0.033***
(0.006) (0.010)
Average health status self rated 20.010** 20.006
(0.005) (0.008)
Average total HH annual income 20.001 0.002
(0.002) (0.005)
*p,0.10, ** p,0.05, *** p,0.010.
www.nature.com/scientificreports
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that the GP plays an important role as gatekeeper and could consult
in favour of doing a smear test. Health status related variables such as
a higher level of distress and a poorer self-perceived health status had
no influence of encouraging or avoiding cervical cancer screenings.
For the socio-economic background variables only employment sta-
tus had an influence whereas other socio-economic background vari-
ables such as household income, education, race, rural or urban
living are not important in our analysis which is contrast to some
other results. A moved residence with a higher chance of not regis-
tering for a new GP plays in our analysis no role for the uptake.
Results for cervical cancer screening in other countries such as US
are not directly comparable to European countries in general, which
have extensive insurance coverage and low direct payments for
health services, and especially to UK with free access to most health
services. As a consequence individual economic factors, especially
income, play not such a role as in US40. Our results are in part in
agreement with results from other studies about cervical screening.
Our analysis found that previous screening, age, living with a partner
and GP visit were significant in different specifications and these
results are consistent with other results for England who estimated
the cervical cancer screening uptake with an unbalanced panel for the
first 12 waves of the BHPS until 200327. However, there are also
marked differences comparing our results with these results.
Estimated coefficients for education, smoking and moved residence
status were not significant in our analysis. Especially the difference in
results for the variable education and smoking are remarkable,
because smoking status as a possible indicator for risky health beha-
viour had surprisingly no influence. However, also some other stud-
ies have found no influence of smoking status on screening
behaviour45. A further study from Italy used as a method a recursive
probit model to analyse the uptake of cervical cancer screening in
Italy. This econometricmodellingwas chosen to reflect the role of the
GP as non-pure gate-keeper, because one or more GP visits can
encourage a woman to do a smear test, however a GP visit is not
essential for the provision of a smear test40. This analysis showed that
GP visits led to a higher uptake of cervical screening. The insti-
tutional setting of this study is similar to the situation in UK, because
cervical cancer screening can be done not only in a GP practice, but it
can be also done at a community clinic.
Underuse of preventative health can also be caused by imperfect
information or individuals who do not evaluate health risks correctly
as for example smokers36 or who decide rationally not to take part in
preventative activity or who decide to run a calculated risk40. It is
sometimes argued that issues surrounding risk depend on socio-
cultural and life experiences of the individuals in question and the
decision to take part in cancer screenings it is not only rational
behaviour46. As further non-economic reasons in not taking part fear
and anxiety can especially be relevant from doing smear tests as
womenmay fear that the screening will reveal cancer and they prefer
not to know47,48. There are possible further non-economic factors
influencing screening uptake and it is argued that factors such as
search for reassurance, a sense of duty and herd signalling could play
a role49. Also a further non-economic factor such as an awareness
campaign for cancer screening50 can influence uptake rates in cancer
screening. However, there is no clear evidence that awareness cam-
paigns promote increased participation, detection and diagnosis of
diseases51.
The innovative feature of our analysis is the analysis of uptake of
cervical cancer screening with a random effects panel probit model
with a balanced sample. Our analysis shows the importance of past
screening behaviour, decreasing participation with recommended
age for cervical cancer screening, the importance of GP for cervical
cancer screening and there is also no effect recognizable of short-
ening the screening interval from 5 to 3 years for women of age 25–49
after 2003. The change of medical guidelines by the NHSCSP has not
led to an increase to an increase of uptake for this age group. A first
limitation of the study is there is no information about results from
previous cervical screening exams available and so it is difficult to
differentiate between routine check-ups and follow-up tests which
are in response to previous results. A second limitation of our study is
that no information was existing about existing health beliefs such as
level of trust in NHS or in GP, because it has been shown that taking
part in cervical and breast cancer screening can be dependent from
them40. A third limitation exists, because there was no information
available about the characteristics of the primary care factors which
have been shown to be associated with cervical cancer screening in
England52. These factors are variables such as the characteristics of
the medical performing of the screening test, structure and organ-
ization of medical centres. Also GPs with a specialisation in the area
of gynaecology and obstetrics have often a higher probability to
recommend preventative treatment31 and also female physicians
have a higher probability to do a pap smear53. A fourth limitation
of our study comes from not using microgeographic information,
because cervical cancer screening coverage was found to be higher in
affluent and less deprived area in Italy54.
Methods
As dataset is the British Household Panel Survey (BHPS) used which is an annual
survey of households in UK and it is a nationally representative sample of more than
5,000 households and each adult with age 16 and over is interviewed55. Data collection
for this survey started in 1991 and the original individuals were also interviewed in the
following years. From the interviewed individuals only female individuals were
included and also women from Northern Ireland were excluded, because data col-
lection started from wave 11.
Our analysis used 17 years of information, from 1992 to 2008 for the unbalanced
panel consisting of 3,758 women and 33,075 observations and for the balanced panel
consisting of 857 women and 11,998 observations. In congruence with the cervical
screening eligibility guidelines in the UK the analysis differentiate between different
age groups of women: age group 16 to 24, age group 25 to 49, age group 50 to 64, age
group 65 and older. Provision of cervical cancer screening for the women had to be
from NHS to be included in our analysis, because there exists also the possibility of
private provision in UK. The dependent variable takes the value of 1 if a cervical
cancer screening was done through NHS provision and 0 if no cervical cancer
screening was done. Pure private provision as well as provision provided both pri-
vately and publicly for cervical cancer screening were excluded in our analysis.
Due to the panel nature of the data on screening and the potential link between
screening behaviour across time, a dynamic random effects (RE) probit model was
estimated. The model is given as
yit~cyt{1zx
0
itbzvit ,i~1,2,:::,N; t~2,:::,T
and
vit~aizuit
and
yit~
1,if ,yit§0
0,otherwise

where (dropping the subscripts) y* denotes the unobservable latent variable, y is the
observed outcome (i.e. participation in cervical cancer screening), x is a vector of
time-varying and time invariant regressors that influence y* (i.e. the propensity to be
screened), b is the vector of coefficients associated with the regressors, ai denotes the
individual specific unobservable effect and uit is a random error.
A dynamic RE specification with lagged screening histories was chosen, because
the aim is not only to capture the influence of the observable characteristics, but also
to explain the actual uptake behaviour by its past values and to capture state
dependence. This specification is chosen, because it removes under certain assump-
tions the bias which is caused by the persistence of the probability of uptake. Crucial
assumptions for the estimation of the dynamic random effect model are the spe-
cification of the relationship between the observed characteristics and the unobserved
time-invariant individual effect and also the distributional assumption on the initial
conditions.
Estimation of a balanced panel was given preference to an unbalanced panel,
because estimation of unbalanced panels with ad hoc treatments of initial problems
has unfavourable estimation properties56,57. One possibility for estimating such a
model is the Wooldridge estimator42. For an unbiased estimation using the
Wooldridge estimator with initial conditions we have to assume that unobserved past
screening behaviour is uncorrelated with observed screening behaviour, i.e. that
unobserved check-ups for cervical screening that happened prior to the first wave of
information in the BHPS are uncorrelated with observed screening. The balanced
model could also be estimated by a maximum likelihood estimator proposed by
Heckman58. A comparison of the estimation properties between the Wooldridge and
Heckman estimator for balanced panels of different period length has shown that the
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finite sample properties of theWooldridge estimator are better for panels ofmoderate
duration (more than 5 to 8 periods) than for the Heckman estimator59, so that our
preferred and used estimator is the Wooldridge estimator. The specific individual
random effect is modelled as Mundlak-Wooldridge specification with a normal
density for the random effect and the first three terms are the initial conditions and
the fourth term is the Mundlak term60:
ai~d1Si1zd2Si2zd3Si3zd4X0izeai
The information about screening behaviour for the first three years of observations on
screening in the BHPS 1991, 1992, 1993 were taken as initial conditions into account
(Si1,Si2,Si3,). X is the average of individual time-varying explanatory variables and eai
is the error term assumed normally distributed with zero mean and standard devi-
ation sa .
Decision to have a smear test depends also from the result of a smear test one year
ago. Women with an inconclusive result from the previous year screening will be
invited to screening in the actual year. The information about the results from pre-
vious screenings is missing in the BHPS. Our econometric specification uses the
information about screening in the previous year and three years ago as lagged
dependent variables, because such a specification considers the institutional setting
with the screening recommendations (3-yearly interval) and a possible unclear smear
test from the previous year.
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